China Resources Pharmaceutical Group Limited (CR Pharma) (Stock Code: 3320.HK) is a leading integrated pharmaceutical company in China specializing in the manufacturing, distribution, and retail of medicines and nutraceutical products. Since the Company went public, it has introduced a number of important capital market indexes, including Hang Seng Composite LargeCap Index, FTSE Global Large Cap Index, Morgan Stanley Capital I...
China Resources Pharmaceutical Group Limited (CR Pharma) (Stock Code: 3320.HK) is a leading integrated pharmaceutical company in China specializing in the manufacturing, distribution, and retail of medicines and nutraceutical products. Since the Company went public, it has introduced a number of important capital market indexes, including Hang Seng Composite LargeCap Index, FTSE Global Large Cap Index, Morgan Stanley Capital International (MSCI) China Index, Hang Seng Stock Connect Hong Kong Index, etc.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.